- Emory scientists studied a new COVID vaccine.
- They tested 24 people who got the 2023–24 shot.
- The vaccine targets the Omicron XBB.1.5 variant.
- Scientists measured different antibodies in blood.
- Many antibodies stayed more than 16 months.
- People made antibodies that see two virus types.
- The 2023–24 shot had one spike protein.
- Earlier shots used two spike proteins.
- Updated vaccines can help older and sick people.
Difficult words
- scientists — a person who studies science and does research
- vaccine — a medicine that helps the body fight a virus
- variant — a different form of the same virus
- antibodies — a protein in blood that fights a virus
- measured — to find the amount or size of something
- spike protein — a part of the virus used to enter cellsspike proteins
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Have you had a COVID shot?
- Do you think vaccines help older people?
Related articles
People learn to use robotic leg prostheses but misjudge their gait
A four-day study found that people who practised with a robotic lower‑limb prosthesis improved their walking but misjudged their own movement. Researchers say better visual feedback could help users calibrate their body image and gait.
Vitamin D may slow diabetes for some people
A new analysis of a large US trial suggests vitamin D supplements might delay progression from prediabetes to type 2 diabetes for people with certain vitamin D receptor gene variations. Researchers warn against taking high doses without medical advice.
Study links syphilis to serious heart problems
Researchers using New Orleans hospital records found people with later-stage syphilis had higher risks of major cardiovascular events, especially when the infection lasted more than a year. The study shows an association but not proof of cause.